Australia's largest stock trading and investment forum Australia's #1 stock forum

PCK

3.23%

3.0¢ painchek ltd

IMO, 10c is a fair valuation including the IP's worth with...

First 16159 Last

Share
Profile

Follow
AlCp

27,387 Posts.

1778

11/07/20

01:05

Post #: 45792723
Share

Originally posted by BertySmythe ↑

At the current share price of 10.5 cents PCK has a mkt cap of $108m

At 31 March the annual recurring revenue was $2.26m (per presentation).

Lets say they get growth in Aust and internationally of 600% in the next few years. That's a fairly huge target. Revenue would then be $13.5m. Margin at 80% (they have quoted 80-85%) would yield about $10.8m gross profit.

Fixed costs per annum are running at about $6m, so lets say at a minimum $7.0m when achieving 600% growth.

Net profit before tax (they would have some tax losses stored up) is therefore $3.8m. When taxes kick in that would be $2.7m

Even at today's price of 10.5 cents that's a P/E of 28 times (or a P/E of 40 times when taxes are paid at 30%)

My point is, as good as the technology and company seem, they do have a lot of work to do to earn the value.

Expand

IMO, 10c is a fair valuation including the IP's worth with Painchek able to acquire half of the dementia market in Australia which will be $10M whether from RCA or DTC but for the MC to get to the next level though, they always need global expansion and that's where I find the use of Painchek problematic (and most know why I think this.....).

Last edited by AlCp: 11/07/20

PCK Price at posting: 10.5¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 4,254 more messages in this thread...

First 16159 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.0¢		Change -0.001(3.23%)		Mkt cap ! $49.11M

Open	High	Low	Value	Volume
3.0¢	3.0¢	3.0¢	$12.08K	402.6K

Buyers (Bids)

No.	Vol.	Price($)
8	305189	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.1¢	99999	1

View Market Depth

No.	Vol.	Price($)
8	305189	0.030
5	6607448	0.029
1	350000	0.028
3	488344	0.027
4	1600000	0.026

Price($)	Vol.	No.
0.031	99999	1
0.032	102605	2
0.033	126161	2
0.034	79638	2
0.035	125000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PCK (ASX) Chart

IMO, 10c is a fair valuation including the IP's worth with...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

IMO, 10c is a fair valuation including the IP's worth with...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News